Loading clinical trials...
Loading clinical trials...
A Phase III Randomized, Active-comparator-Controlled Clinical Trial to Study the Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator, in Subjects From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Conditions
Interventions
Tedizolid phosphate
Comparator
Locations
58
United States
Rady Children's Hospital-San Diego ( Site 0118)
San Diego, California, United States
Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 0129)
Chicago, Illinois, United States
Children's Hospital of Michigan ( Site 0100)
Detroit, Michigan, United States
William Beaumont Hospital ( Site 0108)
Royal Oak, Michigan, United States
St. Louis Children's Hospital ( Site 0127)
St Louis, Missouri, United States
Cook Children's Medical Center ( Site 0124)
Fort Worth, Texas, United States
Start Date
January 20, 2019
Primary Completion Date
July 6, 2023
Completion Date
July 6, 2023
Last Updated
July 31, 2025
Lead Sponsor
Merck Sharp & Dohme LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions